Ezetimibe and Rosuvastatin Combination Treatment Can Reduce the Dose of Rosuvastatin Without Compromising Its Lipid-Lowering Efficacy.

[1]  Daniel E Forman,et al.  2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. , 2019, Journal of the American College of Cardiology.

[2]  J. De Sutter,et al.  Management of dyslipidaemia in patients with coronary heart disease: Results from the ESC-EORP EUROASPIRE V survey in 27 countries. , 2019, Atherosclerosis.

[3]  C. Sirtori,et al.  Can we further optimize statin therapy to increase tolerability? , 2019, Expert opinion on drug discovery.

[4]  S. Yun,et al.  Time‐ and Dose‐Dependent Association of Statin Use With Risk of Clinically Relevant New‐Onset Diabetes Mellitus in Primary Prevention: A Nationwide Observational Cohort Study , 2019, Journal of the American Heart Association.

[5]  Yuan-Lin Guo,et al.  Comparison of statin plus ezetimibe with double-dose statin on lipid profiles and inflammation markers , 2018, Lipids in Health and Disease.

[6]  J. Ferrières,et al.  Low-density lipoprotein cholesterol in a global cohort of 57,885 statin-treated patients. , 2016, Atherosclerosis.

[7]  Peter Sandercock,et al.  Interpretation of the evidence for the efficacy and safety of statin therapy , 2016, The Lancet.

[8]  A. Guerrero,et al.  2015 Clinical Practice Guidelines for the Management of Dyslipidemia in the Philippines - Executive Summary , 2016, ASEAN heart journal : Official journal of the ASEAN Federation of Cardiology.

[9]  Y. Ahn,et al.  Effect of fixed‐dose combinations of ezetimibe plus rosuvastatin in patients with primary hypercholesterolemia: MRS‐ROZE (Multicenter Randomized Study of ROsuvastatin and eZEtimibe) , 2016, Cardiovascular therapeutics.

[10]  Brian A Ference,et al.  Association Between Lowering LDL-C and Cardiovascular Risk Reduction Among Different Therapeutic Interventions: A Systematic Review and Meta-analysis. , 2016, JAMA.

[11]  E. Liberopoulos,et al.  Statin therapy with or without ezetimibe and the progression to diabetes. , 2016, Journal of clinical lipidology.

[12]  Improve-It Investigators.  Ezetimibe added to statin therapy after acute coronary syndromes , 2015 .

[13]  Ž. Reiner,et al.  Adverse effects of statins - myths and reality. , 2015, Current pharmaceutical design.

[14]  Jennifer G. Robinson,et al.  Reprint: 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults. , 2014, Journal of the American Pharmacists Association : JAPhA.

[15]  P. Barter,et al.  Achievement of 2011 European low-density lipoprotein cholesterol (LDL-C) goals of either <70 mg/dl or ≥ 50% reduction in high-risk patients: results from VOYAGER. , 2013, Atherosclerosis.

[16]  J. Guyton,et al.  Intermittent Nondaily Dosing Strategies in Patients with Previous Statin-Induced Myopathy , 2013, The Annals of pharmacotherapy.

[17]  R. Collins,et al.  The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials , 2012, The Lancet.

[18]  Ping Wang.  Statin dose in Asians: is pharmacogenetics relevant? , 2011, Pharmacogenomics.

[19]  Paul Welsh,et al.  Risk of incident diabetes with intensive-dose compared with moderate-dose statin therapy: a meta-analysis. , 2011, JAMA.

[20]  L Zhang,et al.  The Role of Ethnicity in Variability in Response to Drugs: Focus on Clinical Pharmacology Studies , 2008, Clinical pharmacology and therapeutics.

[21]  J. Mckenney,et al.  National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) , 2015 .

[22]  Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. , 2002, Circulation.